Cargando…

The impact of multi-target stool DNA testing in clinical practice in the United States: A real-world evidence retrospective study

Widely endorsed screening modalities for colorectal cancer (CRC) include structural visualization (e.g. colonoscopy) and stool-based tests including multitarget stool DNA (mt-sDNA), fecal immunochemical tests (FIT), or high-sensitivity guaiac-based fecal occult blood tests (gFOBT). However, CRC scre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miller-Wilson, Lesley-Ann, Limburg, Paul, Helmueller, Leah, João Janeiro, Maria, Hartlaub, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747652/ https://www.ncbi.nlm.nih.gov/pubmed/36531100 http://dx.doi.org/10.1016/j.pmedr.2022.102045

Ejemplares similares

Opportunities and Challenges in Screening for Colorectal Cancer
por: Miller Wilson, Lesley-Ann, et al.
Publicado: (2023)

Colorectal screening among average risk individuals in the United States, 2015–2018
por: Engel-Nitz, Nicole M., et al.
Publicado: (2022)

Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening in a medicaid population
por: Miller-Wilson, Lesley-Ann, et al.
Publicado: (2022)

Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening in a large, nationally insured cohort
por: Miller-Wilson, Lesley-Ann, et al.
Publicado: (2021)

What do ‘false-positive’ stool tests really mean? Data from the New Hampshire colonoscopy registry
por: Butterly, Lynn F., et al.
Publicado: (2023)

Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening: Real-world data from a large cohort of older adults
por: Weiser, Emily, et al.
Publicado: (2020)

Evaluation of a multimedia outreach campaign for a multi-target stool DNA test for colorectal cancer screening among non-medicare employer population in the United States
por: Shepherd, Martha E., et al.
Publicado: (2022)

Evaluating Outreach Methods for Multi-Target Stool DNA Test for Colorectal Cancer Screening Among an Employer Population
por: Shepherd, Martha E., et al.
Publicado: (2021)

Real-World Management of High Stool Output in Patients with Short Bowel Syndrome: An International Multicenter Survey
por: Lakananurak, Narisorn, et al.
Publicado: (2023)

Out-of-Pocket Costs for Colonoscopy After Noninvasive Colorectal Cancer Screening Among US Adults With Commercial and Medicare Insurance
por: Fendrick, A. Mark, et al.
Publicado: (2021)

Assessment of Stool DNA Markers to Detect Colorectal Neoplasia in Patients with Inflammatory Bowel Disease: A Multi-site Case-control Study
por: Itzkowitz, Steven, et al.
Publicado: (2023)

Three-Year Interval for the Multi-Target Stool DNA Test for Colorectal Cancer Screening: A Longitudinal Study
por: Imperiale, Thomas F., et al.
Publicado: (2023)

Challenges in Phase 4 post-licensure safety studies using real world data in the United States: Hepatitis B vaccine example
por: Bruxvoort, Katia, et al.
Publicado: (2021)

Utilization of a Colorectal Cancer Screening Test Among Individuals With Average Risk
por: Fisher, Deborah A., et al.
Publicado: (2021)

Comparison of Simulated Outcomes Between Stool- and Blood-Based Colorectal Cancer Screening Tests
por: Fendrick, A. Mark, et al.
Publicado: (2023)

Long-Term Real-World Effectiveness of Pharmacotherapies for Schizoaffective Disorder
por: Lintunen, Jonne, et al.
Publicado: (2021)

A critical view on the real-world security of logic locking
por: Engels, Susanne, et al.
Publicado: (2022)

Patient and provider factors associated with colorectal cancer screening among average risk health plan enrollees in the US, 2015–2018
por: Engel-Nitz, Nicole M., et al.
Publicado: (2023)

Stool-Based Colorectal Cancer Screening Test Performance Characteristics in Those With and Without Hemorrhoids
por: Ebner, Derek W., et al.
Publicado: (2023)

Factors influencing colorectal cancer screening decision-making among average-risk US adults
por: Zhu, Xuan, et al.
Publicado: (2022)

Development of an Index Score for Intestinal Inflammation-Associated Dysbiosis Using Real-World Stool Test Results
por: Chen, Lihong, et al.
Publicado: (2019)

Presence of Giardia lamblia in stools of six‐ to 18‐month old asymptomatic Malawians is associated with children's growth failure
por: Lehto, Kirsi‐Maarit, et al.
Publicado: (2019)

Impact of Patient Adherence to Stool-Based Colorectal Cancer Screening and Colonoscopy Following a Positive Test on Clinical Outcomes
por: Fendrick, A. Mark, et al.
Publicado: (2021)

Adherence to fecal immunochemical test screening among adults at average risk for colorectal cancer
por: Fisher, Deborah A., et al.
Publicado: (2021)

Real-world effectiveness of caplacizumab vs the standard of care in immune thrombotic thrombocytopenic purpura
por: Izquierdo, Cristina Pascual, et al.
Publicado: (2022)

Study protocol: Evaluation of the ‘real-world’ Farmers Have Hearts – Cardiovascular Health Program
por: van Doorn, Diana, et al.
Publicado: (2022)

Real-world upper endoscopy utilization patterns among patients with gastroesophageal reflux disease, Barrett esophagus, and Barrett esophagus-related esophageal neoplasia in the United States
por: Sharma, Prateek, et al.
Publicado: (2023)

Cost-Effectiveness of Outreach Strategies for Stool-Based Colorectal Cancer Screening in a Medicaid Population
por: Karlitz, Jordan J., et al.
Publicado: (2022)

Life-years gained resulting from screening colonoscopy compared with follow-up colonoscopy after a positive stool-based colorectal screening test
por: Mark Fendrick, A., et al.
Publicado: (2022)

Barriers to utilization of three colorectal cancer screening options – Data from a national survey
por: Zhu, Xuan, et al.
Publicado: (2021)

Unequal impacts of the COVID-19 pandemic on women's fertility preferences: Evidence from a longitudinal cohort in the United States
por: Koenig, Leah R., et al.
Publicado: (2022)

Validating atlas-based lesion disconnectomics in multiple sclerosis: A retrospective multi-centric study
por: Ravano, Veronica, et al.
Publicado: (2021)

Real-Time, Multiplexed SHERLOCK for in Vitro Diagnostics
por: Pena, Jennifer M., et al.
Publicado: (2023)

Cost-Effectiveness of Waiving Coinsurance for Follow-Up Colonoscopy after a Positive Stool-Based Colorectal Screening Test in a Medicare Population
por: Fendrick, A. Mark, et al.
Publicado: (2022)

Impact of Eliminating Cost-Sharing by Medicare Beneficiaries for Follow-Up Colonoscopy After a Positive Stool-based Colorectal Cancer Screening Test
por: Fendrick, A. Mark, et al.
Publicado: (2023)

Neural signal during immediate reward anticipation in schizophrenia: Relationship to real-world motivation and function
por: Subramaniam, Karuna, et al.
Publicado: (2015)

Brand-Name Antidepressants Outperform Their Generic Counterparts in Preventing Hospitalization for Depression: The Real-World Evidence from Taiwan
por: Hsu, Chih-Wei, et al.
Publicado: (2020)

Differentiation of schizophrenia using structural MRI with consideration of scanner differences: A real‐world multisite study
por: Nemoto, Kiyotaka, et al.
Publicado: (2019)

Rates of Follow-up Colonoscopy After a Positive Stool-Based Screening Test Result for Colorectal Cancer Among Health Care Organizations in the US, 2017-2020
por: Mohl, Jeff T., et al.
Publicado: (2023)

The impact of increasing multitarget stool DNA use among colorectal cancer screeners in a self-insured US employer population
por: Hathway, Joanne M, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9jjq8l2jp992mo6l4coqo9ec0c